Pharmacokinetics of ceftazidime administered to lactating and non-lactating goats

cic.isFulltexttruees
cic.isPeerReviewedtruees
cic.lugarDesarrolloUniversidad Nacional de La Plata es
cic.versioninfo:eu-repo/semantics/submittedVersiones
dc.date.accessioned2016-08-10T16:15:40Z
dc.date.available2016-08-10T16:15:40Z
dc.identifier.urihttps://digital.cic.gba.gob.ar/handle/11746/3531
dc.titlePharmacokinetics of ceftazidime administered to lactating and non-lactating goatsen
dc.typeArtículoes
dcterms.abstractThe aim of this work was to determine the pharmacokinetics of intravenous (iv) and intramuscular (im) ceftazidime administered to lactating (LTG; n = 6) and non-lactating (NLTG; n=6) healthy Creole goats in 2 trials (T1 and T2). During T1 and T2, goats randomly received a single dose of im or iv ceftazidime (10 mg/kg). Serum concentration of iv ceftazidime in NLTG and LTG goats is best described by 2 and 3 compartment models, respectively. The pharmacokinetic parameters of iv and im ceftazidime administered to LTGandNLTGshowed statistically significant differences (P<0.05) in the constants (äz, T1 vs T2 [iv] 0.5±0.1 vs 0.3±0.1 /h; T1 vs T2 [im] 0.5±0.2 vs 0.3±0.1 /h) and in the mean times (t1/2, T 1 vs T 2 [iv] 1.6±0.3 vs 2.3±0.6 h; T 1 vs T 2 [im] 1.6±0.7 vs 2.6±0.9 h) of elimination. The bioavailability of ceftazidime in LTG and NLTG was 113.0 ± 17.8 and 96.0 ± 18.0 %, respectively. Ceftazidime concentration in milk at 2 h was: iv = 1.9 ± 0.2 and im = 2.4 ± 0.5 μg/m; the penetration in milk was iv = 18.3 ± 13.5 and im = 14.3 ± 10.6 %. Ninety-six hours after iv and im administration, residues of the drug were not found in milk. In conclusion, ceftazidime, when administered to goats, showed high concentration times in serum, good penetration into milk and a bioavailability that makes it suitable to be used by the im route.en
dcterms.creator.authorVillagra, Sergioes
dcterms.creator.authorBarrena, Jorge Pabloes
dcterms.creator.authorLacchini, Raúles
dcterms.creator.authorRule, Robertoes
dcterms.creator.authorReynaldi, Francisco J.es
dcterms.extent5 p.es
dcterms.identifier.urlRegistro completoes
dcterms.isPartOf.issuevol. 82, no. 4es
dcterms.isPartOf.seriesJournal of the South African Veterinary Associationes
dcterms.issued2011-01-01
dcterms.languageIngléses
dcterms.licenseAttribution 4.0 International (BY 4.0)es
dcterms.subjectceftazidimeen
dcterms.subjectarticleen
dcterms.subjectcontrolled studyen
dcterms.subjectdrug absorptionen
dcterms.subjectdrug bioavailabilityen
dcterms.subjectdrug blood levelen
dcterms.subjectdrug distributionen
dcterms.subjectdrug eliminationen
dcterms.subjectdrug half lifeen
dcterms.subjectdrug penetrationen
dcterms.subjectgoaten
dcterms.subjectlactationen
dcterms.subjectmilken
dcterms.subjectnonhumanen
dcterms.subjectceftazidimeen
dcterms.subjectgoaten
dcterms.subjectmilken
dcterms.subjectpharmacokineticsen
dcterms.subjectFarmacocinéticaes
dcterms.subjectAbsorciónes
dcterms.subjectLactanciaes
dcterms.subject.materiaCiencias Veterinariases
dcterms.subject.materiaBioquímica y Biología Moleculares

Archivos

Bloque original

Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
rule - pharmacokinetics.pdf-PDFA.pdf
Tamaño:
413.07 KB
Formato:
Adobe Portable Document Format
Descripción:
Documento completo